Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minghui Duan

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Therapeutic Advances in Hematology|September 15, 2022
Efficacy and safety of ruxolitinib in patients with myelofibrosis and low platelet count (50 × 10<sup>9</sup>/L to <100 × 10<sup>9</sup>/L) at baseline: the final analysis of EXPANDPaola Guglielmelli, Jean-Jacques Kiladjian, Alessandro M Vannucchi, et al.
American Journal of Hematology|July 20, 2023
Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are intolerant to ruxolitinib: A single-arm, open-label, phase 2, multicenter studyYi Zhang, Hu Zhou, Minghui Duan, et al.
Experimental Hematology & Oncology|June 21, 2023
A new dosing regimen of ropeginterferon alfa-2b is highly effective and tolerable: findings from a phase 2 study in Chinese patients with polycythemia veraJie Jin, Lei Zhang, Albert Qin, et al.
Current Hematologic Malignancy Reports|July 11, 2025
Highlights from MPN Asia 2025: Advances in Molecular Pathogenesis and Therapeutic Strategies in Myeloproliferative NeoplasmsPrithviraj Bose, Zhijian Xiao, Hans C Hasselbalch, et al.
Acta Haematologica|October 21, 2025
Discrepancies in Treatment Goals and Concerns Regarding Disease Management between Patients with Myeloproliferative Neoplasms and Hematologists in China: Analysis from a Multicenter Cross-Sectional SurveyJunling Zhuang, Hongxia Shi, Xiaoli Liu, et al.
Leukemia & Lymphoma|June 8, 2021
Variables associated with patient-reported outcomes in patients with myeloproliferative neoplasmsDayu Shi, Hongxia Shi, Xiaoli Liu, et al.
Acta Haematologica|February 22, 2023
Patient-Reported Outcomes in Young Adults with Myeloproliferative NeoplasmsMei Bao, Mengyu Zhang, Hongxia Shi, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Therapeutic Advances in Hematology|September 15, 2022
Efficacy and safety of ruxolitinib in patients with myelofibrosis and low platelet count (50 × 10<sup>9</sup>/L to <100 × 10<sup>9</sup>/L) at baseline: the final analysis of EXPANDPaola Guglielmelli, Jean-Jacques Kiladjian, Alessandro M Vannucchi, et al.
American Journal of Hematology|July 20, 2023
Safety and efficacy of jaktinib (a novel JAK inhibitor) in patients with myelofibrosis who are intolerant to ruxolitinib: A single-arm, open-label, phase 2, multicenter studyYi Zhang, Hu Zhou, Minghui Duan, et al.
Experimental Hematology & Oncology|June 21, 2023
A new dosing regimen of ropeginterferon alfa-2b is highly effective and tolerable: findings from a phase 2 study in Chinese patients with polycythemia veraJie Jin, Lei Zhang, Albert Qin, et al.
Current Hematologic Malignancy Reports|July 11, 2025
Highlights from MPN Asia 2025: Advances in Molecular Pathogenesis and Therapeutic Strategies in Myeloproliferative NeoplasmsPrithviraj Bose, Zhijian Xiao, Hans C Hasselbalch, et al.
Acta Haematologica|October 21, 2025
Discrepancies in Treatment Goals and Concerns Regarding Disease Management between Patients with Myeloproliferative Neoplasms and Hematologists in China: Analysis from a Multicenter Cross-Sectional SurveyJunling Zhuang, Hongxia Shi, Xiaoli Liu, et al.
Leukemia & Lymphoma|June 8, 2021
Variables associated with patient-reported outcomes in patients with myeloproliferative neoplasmsDayu Shi, Hongxia Shi, Xiaoli Liu, et al.
Acta Haematologica|February 22, 2023
Patient-Reported Outcomes in Young Adults with Myeloproliferative NeoplasmsMei Bao, Mengyu Zhang, Hongxia Shi, et al.
Pageof 7